• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu
VIEW ALL RESEARCH-GROUP

Susceptibility, tumor progression and resistance
Pujana’s Lab

DESCRIPTION

Targeting cancer complexity at origin and progression

Our research is focused on better understanding breast cancer initiation and, from acquired knowledge, to assess targeted prevention strategies. In parallel, we study pan-cancer vulnerabilities and the connection to a rare, lung metastatic disease, lymphangioleiomyomatosis (LAM).

Group members

Miquel Angel Pujana

Group leaders

Principal investigator

Francesca Mateo

Researchers

Research assistant

Roderic Espín

Young investigators

PhD student

Lara Ruiz

Young investigators

PhD student

Arzoo Shabbir

Young investigators

PhD student

    Luís Alfaro

    Young investigators

    PhD student

    Publications

    DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders

    20 de September de 2017/in Pujana's Lab/by miguel

    Sci Rep. 2017 Sep 18;7(1):11762. doi: 10.1038/s41598-017-12084-1. ABSTRACT This work provides a comprehensive CpG methylation landscape of the different layers of the human eye that unveils the gene networks associated with their biological functions and how these are disrupted in common visual disorders. Herein, we firstly determined the role of CpG methylation in the regulation […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-09-20 10:00:002017-09-20 10:00:00DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders

    Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

    28 de April de 2017/in Pujana's Lab/by miguel

    J Clin Oncol. 2017 Jul 10;35(20):2240-2250. doi: 10.1200/JCO.2016.69.4935. Epub 2017 Apr 27. ABSTRACT Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time to our knowledge-associations of common genetic variants with breast and prostate cancer […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-04-28 10:00:002017-04-28 10:00:00Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

    BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells

    22 de April de 2017/in Pujana's Lab/by miguel

    Oncotarget. 2017 May 16;8(20):32461-32475. doi: 10.18632/oncotarget.15688. ABSTRACT BRCA1 deficiency may perturb the differentiation hierarchy present in the normal mammary gland and is associated with the genesis of breast cancers that are genomically unstable and typically display a basal-like transcriptome. Oriented cell division is a mechanism known to regulate cell fates and to restrict tumor formation. […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-04-22 10:00:002017-04-22 10:00:00BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells

    Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    28 de March de 2017/in Pujana's Lab/by miguel

    Nat Genet. 2017 May;49(5):680-691. doi: 10.1038/ng.3826. Epub 2017 Mar 27. ABSTRACT To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-03-28 10:00:002017-03-28 10:00:00Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy

    12 de February de 2017/in Pujana's Lab/by miguel

    J Invest Dermatol. 2017 Jun;137(6):1297-1310. doi: 10.1016/j.jid.2017.01.021. Epub 2017 Feb 7. ABSTRACT The cell cycle-related genes AURKA and FOXM1 are overexpressed in melanoma. We show here that AURKA overexpression is associated with poor prognosis in three independent cohorts of melanoma patients and correlates with the presence of genomic amplification of AURKA locus and BRAFV600E mutation. […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2017-02-12 11:00:002017-02-12 11:00:00AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy
    Page 15 of 23«‹1314151617›»

    Research Projects

    The group works and collaborates to decipher the systems mechanisms of cancer development and progression, with the aim of developing more precise preventive and therapeutic approaches. The group combines in silico and wet-lab studies for the purpose of identifying cancer principles and vulnerabilities.

    Collaborations

    CIMBA – Consortium of Investigators of Modifiers of BRCA1/2

    https://cimba.ccge.medschl.cam.ac.uk/

    Lobular Breast Cancer

    https://lobsterpot.eu/

    BRCA1 breast cancer

    Khokha Lab

    https://medbio.utoronto.ca/faculty/khokha

    Hakem Lab

    https://medbio.utoronto.ca/faculty/hakem

    Maxwell Lab

    https://www.bcchr.ca/cmaxwell

    Serra Lab

    https://vhio.net/biosketch-violeta-serra/

    Cancer biology

    Schramek Lab

    https://schramek.lunenfeld.ca/

    Li Lab

    https://lilab.smhs.gwu.edu/

    Barcellos-Hoff Lab

    https://barcelloshofflab.ucsf.edu/principal-investigator

    Cancer genetics

    De Cid Lab – GCAT

    http://www.gcatbiobank.org/

    LAM research

    Johnson Lab – LAM UK

    https://www.nottingham.ac.uk/medicine/people/simon.johnson

    Elżbieta Radzikowska

    National Tuberculosis and Lung Diseases Research Institute, Poland

    Kwiatkowski Lab

    https://www.kwiatkowskilab.org/

    AELAM

    https://www.aelam.org/

    VHIR

    https://vhir.vallhebron.com/en/research/pneumology

    Molina Lab

    https://idibell.cat/en/research/translational-medicine-area/cardiovascular-respiratory-and-systemic-diseases-and-cellular-aging-program/pneumology/

    Research group photo.Pujana's Lab
    Program Against Cancer Therapeutic Resistance

    CONTACT US

    Campus IDIBELL
    (L’Hospitalet del Llobregat)
    Hospital Duran i Reynals, Gran Via 199,
    L’Hospitalet del Llobregat,
    Barcelona 08908
    Tel. +34 93 260 7952

    Campus IGTP-IJC
    (Badalona)
    Campus Can Ruti – IGTP – Building Muntanya,
    Rd. Can Ruti, Camí de les escoles s/n,
    Badalona, Barcelona 08916
    Tel. +34 93 554 3069

    Campus IDIBGI
    (Girona)
    Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
    Salt, Girona 17190
    Tel. +34 872 987 087

    © Copyright - Edisenius
    • Privacy Policy
    • Cookie Policy
    • Legal Notice
    Belver’s LabBelver's LabMenendez's LabMenendez’s Lab
    Scroll to top
    Manage cookie consent
    To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
    Functional Always active
    Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
    Marketing
    Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    See preferences
    {title} {title} {title}